Guardion Health Sciences GHSI
$ 3.25
-0.31%
Quarterly report 2024-Q2
added 08-13-2024
Guardion Health Sciences Balance Sheet 2011-2024 | GHSI
Annual Balance Sheet Guardion Health Sciences
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-4.07 M | -8.08 M | -10.5 M | -671 K | -4.7 M | 8.86 K | 758 K | - | - | - | - | |
Long Term Debt |
- | 3.81 K | - | - | - | - | - | 517 K | - | - | - | - |
Long Term Debt Current |
3.81 K | 22.2 K | 163 K | 152 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 272 K | 435 K | - | - | - | 517 K | - | - | - | - |
Total Current Liabilities |
4.01 M | 1.16 M | 1.07 M | 410 K | 495 K | 500 K | 608 K | - | - | - | - | - |
Total Liabilities |
8.52 M | 1.16 M | 1.35 M | 845 K | 495 K | 500 K | 608 K | 1.47 M | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-93.7 M | -78.8 M | -54.1 M | -45.5 M | -34.6 M | -26.9 M | -20.7 M | -14.1 M | - | - | - | - |
Total Assets |
21.7 M | 23.5 M | 9.86 M | 12.9 M | 3.68 M | 7.37 M | 262 K | 246 K | - | - | - | - |
Cash and Cash Equivalents |
10.7 M | 4.09 M | 8.52 M | 11.1 M | 671 K | 4.74 M | 62.5 K | 13.8 K | - | - | - | - |
Book Value |
13.2 M | 22.3 M | 8.52 M | 12 M | 3.19 M | 6.87 M | -346 K | -1.23 M | - | - | - | - |
Total Shareholders Equity |
7.92 M | 22.3 M | 8.52 M | 12 M | 3.19 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Guardion Health Sciences
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | 3.81 K | - | 186 K | 229 K | 272 K | 272 K | 272 K | 272 K | 435 K | 435 K | 435 K | 435 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 272 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.55 M | 6.99 M | 3.77 M | 5.18 M | 6.23 M | 5.94 M | 8.52 M | 1.73 M | 1.69 M | 1.83 M | 1.16 M | 1.97 M | 1.99 M | 1.21 M | 1.35 M | 1.35 M | 1.35 M | 1.35 M | 845 K | 845 K | 845 K | 845 K | 495 K | 495 K | 495 K | 495 K | - | - | - | - | 608 K | - | - | - | 1.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 438 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-88 M | -98.3 M | -93.6 M | -94 M | -94.4 M | -93.2 M | -93.7 M | -84.8 M | -83.1 M | -81.4 M | -78.8 M | -64.3 M | -61.3 M | -56.7 M | -54.1 M | -54.1 M | -54.1 M | -54.1 M | -45.5 M | -45.5 M | -45.5 M | -45.5 M | -34.6 M | -34.6 M | -34.6 M | -34.6 M | -26.9 M | -26.9 M | -26.9 M | -26.9 M | -20.7 M | -20.7 M | -20.7 M | -20.7 M | -14.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
15.3 M | 10.4 M | 11.9 M | 12.9 M | 13.5 M | 14.4 M | 21.7 M | 28.2 M | 29.8 M | 31.6 M | 23.5 M | 38.6 M | 41.3 M | 44.7 M | 9.86 M | 9.86 M | 9.86 M | 9.86 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 3.68 M | 3.68 M | 3.68 M | 3.68 M | 7.37 M | 7.37 M | 7.37 M | 7.37 M | 262 K | 262 K | 262 K | 262 K | 246 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
14.8 M | 5.61 M | 6.36 M | 7.66 M | 8.37 M | 8.77 M | 10.7 M | 12.9 M | 4.22 M | 4.83 M | 4.09 M | 3.56 M | 5.5 M | 43.3 M | 8.52 M | 8.52 M | 8.52 M | 8.52 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 671 K | 671 K | 671 K | 671 K | 4.74 M | 4.74 M | 4.74 M | 4.74 M | 62.5 K | 62.5 K | 62.5 K | 62.5 K | 13.8 K | - | - | - | 6.16 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
13.8 M | 3.41 M | 8.15 M | 7.7 M | 7.24 M | 8.48 M | 13.2 M | 26.5 M | 28.1 M | 29.8 M | 22.3 M | 36.6 M | 39.3 M | 43.5 M | 8.52 M | 8.52 M | 8.52 M | 8.52 M | 12 M | 12 M | 12 M | 12 M | 3.19 M | 3.19 M | 3.19 M | 3.19 M | 7.37 M | 7.37 M | 7.37 M | 7.37 M | -346 K | 262 K | 262 K | 262 K | -1.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
13.8 M | 3.41 M | 8.15 M | 7.7 M | 7.24 M | 8.48 M | 7.92 M | 21.3 M | 22 M | 18.3 M | 22.3 M | 36.6 M | 39.3 M | 43.5 M | 8.52 M | 8.52 M | 8.52 M | 8.52 M | 12 M | 12 M | 12 M | 12 M | 3.19 M | 3.19 M | 3.19 M | 3.19 M | 6.87 M | - | 256 K | 154 K | 346 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency